ClinicalTrials.gg
Drug

Piflufolastat clinical trials

Also written 18F-DCFPyL and PYLARIFY.

studies test it
30
open now
5
in phase 3
5
first study started
2014

How each study uses piflufolastat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the piflufolastat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
27 Nov 2023 · Pylclari · EMEA/H/C/005520 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

18F-DCFPyL Injection
5
PyL
4
Piflufolastat F18
2
Piflufolastat F-18
2
Fluorine F 18 DCFPyL
2

Brand

PYLARIFY
5

Other names

18F-DCFPyL
17
(18F)DCFPyL
1

Studies by the year they started

30 studies that test it; most in 2024 (5)

Studies that test piflufolastat, by start year
YearStudies
20141
20152
20163
20172
20184
20193
20201
20212
20222
20233
20245
20252

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
4
Phase 2
16
Phase 3
5
Phase 4
5
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 25

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (7) · National Cancer Institute (NCI) (5) · Lantheus Medical Imaging (2) · Progenics Pharmaceuticals, Inc. (2) · M.D. Anderson Cancer Center (1) · Columbia University (1) · University of Wisconsin, Madison (1) · Blue Earth Diagnostics (1)

Often tested with

Tested in the same studies.

Sodium fluoride f-18 (2) · PSMA-11 (1) · Flotufolastat F 18 (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2

Studies that test piflufolastat.

Studies

Open first, then newest update. How each study uses piflufolastat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 30

See all 30 studies that test piflufolastat →

Given beside what is tested · 2 — piflufolastat is usual care or a partner of the new treatment

Codes

What other systems call piflufolastat · ClinicalTrials.gg INT006070

  • MeSH (NLM) C572626piflufolastatConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 82VH67YON8PIFLUFOLASTATConfirmed NLM, Wikidata
  • RxNorm 2556617One source FDA
  • Wikidata Q27269357piflufolastatConfirmed NLM, Wikidata

Also registered as piflufolastat f-18 (UNII 3934EF02T7 · RxNorm 2556616).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.